Article
Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis.
Science advances - 1 Mar 2017
Wang Liuyang, Ko Emily R, Gilchrist James J, Pittman Kelly J, Rautanen Anna, Pirinen Matti, Thompson J Will, Dubois Laura G, Langley Raymond J, Jaslow Sarah L, Salinas Raul E, Rouse D Clayburn, Moseley M Arthur, Mwarumba Salim, Njuguna Patricia, Mturi Neema, Williams Thomas N, Scott J Anthony G, Hill Adrian V S, Woods Christopher W, Ginsburg Geoffrey S, Tsalik Ephraim L, Ko Dennis C
Abstract excerpt
Sepsis is a deleterious inflammatory response to infection with high mortality. Reliable sepsis biomarkers could improve diagnosis, prognosis, and treatment. Integration of human genetics, patient metabolite and cytokine measurements, and testing in a mouse model demonstrate that the methionine salvage pathway is a regulator of sepsis that can accurately predict prognosis in patients. Pathway-based genome-wide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
